As of 2025-09-17, the Relative Valuation of Nova Mentis Life Science Corp (NOVA.CN) is (1.28) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.04 CAD, the upside of Nova Mentis Life Science Corp based on Relative Valuation is -3312.5%.
The range of the Relative Valuation is (1.66) - (0.81) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 36.6x - 42.1x | 39.3x |
| Forward P/E multiples | 16.8x - 18.0x | 17.4x |
| Fair Price | (1.66) - (0.81) | (1.28) |
| Upside | -4239.2% - -2135.6% | -3312.5% |
| Date | P/E |